Bloom Health Partners Inc.

CNSX:BLMH Stock Report

Market Cap: CA$3.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bloom Health Partners Valuation

Is BLMH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BLMH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BLMH (CA$0.08) is trading below our estimate of fair value (CA$21.2)

Significantly Below Fair Value: BLMH is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BLMH?

Key metric: As BLMH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for BLMH. This is calculated by dividing BLMH's market cap by their current earnings.
What is BLMH's PE Ratio?
PE Ratio1.1x
EarningsCA$3.58m
Market CapCA$3.81m

Price to Earnings Ratio vs Peers

How does BLMH's PE Ratio compare to its peers?

The above table shows the PE ratio for BLMH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average104.8x
SUNREST Sunrest Lifescience
104.7xn/a₹244.6m
530057 Vivanza Biosciences
227.6xn/a₹162.0m
BKZ Suntar Eco-City
61.6xn/aS$7.9m
SAROJA Saroja Pharma Industries India
25.2xn/a₹217.1m
BLMH Bloom Health Partners
1.1xn/aCA$3.8m

Price-To-Earnings vs Peers: BLMH is good value based on its Price-To-Earnings Ratio (1.1x) compared to the peer average (23.8x).

Price to Earnings Ratio vs Industry

How does BLMH's PE Ratio compare vs other companies in the North American Healthcare Industry?

4 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.24.0x52.8%
BLMH Bloom Health Partners
 1.1xn/aUS$2.85m
BLMH 1.1xIndustry Avg. 24.0xNo. of Companies13PE01632486480+
4 CompaniesEstimated GrowthMarket Cap
Industry Avg.24.0x52.8%
BLMH Bloom Health Partners
 1.1xn/aUS$2.85m
No more companies

Price-To-Earnings vs Industry: BLMH is good value based on its Price-To-Earnings Ratio (1.1x) compared to the North American Healthcare industry average (24.4x)

Price to Earnings Ratio vs Fair Ratio

What is BLMH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BLMH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio1.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BLMH's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

dentalcorp Holdings

CA$1.9b

Through its subsidiaries, engages in the acquiring and partnering with dental practices to provide health care services in Canada.

DNTL

CA$10.16

7D

2.8%

1Y

73.4%

NeuPath Health

CA$9.3m

Provides chronic pain management services in Canada.

NPTH

CA$0.16

7D

-3.0%

1Y

0%

WELL Health Technologies

CA$1.3b

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

WELL

CA$5.02

7D

1.8%

1Y

35.3%